Status report of lipid-lowering trials in diabetes

The prevention and treatment of coronary heart disease is a major challenge in the overall management of the patient with type 2 diabetes. Diabetic dy slipidaemia is an important risk factor and is open to therapeutic interven tion. However, as yet there are no primary or secondary coronary heart dise ase prevention trials of lipid-lowering therapy reported in diabetic popula tions. In this review, on-going clinical trials of lipid-lowering therapy i n specific diabetic populations will be described. Curr Opin Lipidol 11:621 -626. (C) 2000 Lippincott Williams & Wilkins.